Various methods were employed to measure gastric emptying in studies that included patients taking different GLP-1 medications, including both long-acting and short-acting formulations
Of note, ex vivo isolated islet experiments do not simulate the full range of regulation present in vivo under T2DM conditions [207], which requires further investigation to clarify
Mistake 6: Injecting into the wrong tissue layer GLP-1 medications are designed for subcutaneous injection, meaning into the fat layer between the skin and the muscle
Obesity leads to chronic inflammation, he said, and that inflammation has very clear effects on your arteries and your cardiovascular system. Reducing that inflammation with GLP-1s, it turns out, reduces cardiovascular risk
"Latest Medical News, Clinical Trials, Guidelines - Today on Medscape"